![Christopher Missling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Missling
No open positions remaining
Net worth: 4 M $ as of 30/08/2026
Profile
Dr. Christopher U.
Missling was previously employed as a Head-Financial Planning by Aventis, Inc., a Head-Healthcare Investment Banking by Brimberg & Co., a CFO & Senior Vice President-Strategic Operations by Curis, Inc., and a Chief Financial Officer by ImmunoGen, Inc. He also served on the board at Anavex Life Sciences Corp.
He received his graduate degree from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, an MBA from Kellogg School of Management and a doctorate degree from Ludwig-Maximilians-Universität München.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/07/2026 | 1,510,165 ( 1.63% ) | 4 M $ | 30/08/2026 |
Former positions of Christopher Missling
| Companies | Position | End |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Chief Executive Officer | 29/04/2026 |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Director of Finance/CFO | - |
| CURIS, INC. | Director of Finance/CFO | - |
Training of Christopher Missling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WHU-Otto Beisheim School of Management
 WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Christopher Missling
